India Glycols (BOM:500201) Total Operating Expense: ₹10,555 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500201 India Glycols Ltd BOM:500201
66 GF Score
Price ₹1,143.10
GF Value ₹757.98
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is India Glycols Total Operating Expense?

India Glycols BOM:500201 -1.55% 66 Total Operating Expense is ₹10,555 Mil as of Mar. 2026. GuruFocus rates BOM:500201 with a GF Score™ of 66/100 and a GF Value™ of ₹757.98 (Significantly Overvalued). The stock has 6 warning signs investors should review.

India Glycols's Total Operating Expense for the three months ended in Mar. 2026 was ₹2,441 Mil. India Glycols's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹10,555 Mil.

India Glycols Total Operating Expense Related Terms

India Glycols Total Operating Expense Historical Data

* Premium members only.

The historical data trend for India Glycols's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

India Glycols Total Operating Expense Chart

India Glycols Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,257.05 7,115.66 7,360.69 9,646.70 10,555.40

India Glycols Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,159.80 2,478.00 2,871.90 2,764.30 2,441.20
BOM:500201
66GF Score
India Glycols Ltd BOM:500201
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

India Glycols Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹10,555 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹10,555 Mil mean?
India Glycols (BOM:500201) has a Total Operating Expense of ₹10,555 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on India Glycols and its competitors.
Is India Glycols' Total Operating Expense too high?
India Glycols' current Total Operating Expense is ₹10,555 Mil. Overall, India Glycols has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does India Glycols' Total Operating Expense compare to DOW?
India Glycols' Total Operating Expense of ₹10,555 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Chemicals company?
A good Total Operating Expense depends on the Chemicals industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on India Glycols and its competitors. India Glycols's current Total Operating Expense is ₹10,555 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is India Glycols stock overvalued right now?
Based on GuruFocus' analysis, India Glycols (BOM:500201) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹757.98, compared to a current price of ₹1,143.10 — trading 50.8% above its estimated fair value. The current Total Operating Expense is ₹10,555 Mil. India Glycols' overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For India Glycols (BOM:500201), the current Total Operating Expense is ₹10,555 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is India Glycols (BOM:500201) Overvalued in 2026?

Based on GuruFocus' analysis, India Glycols stock appears to be overvalued. The current stock price of ₹1,143.10 is trading 50.8% above its estimated GF Value™ of ₹757.98. GuruFocus considers India Glycols to be Significantly Overvalued.

Key valuation signals for BOM:500201:

  • Total Operating Expense: ₹10,555 Mil
  • GF Value™: ₹757.98 vs. price of ₹1,143.10 (50.8% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the BOM:500201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

India Glycols Business Description

Other Exchanges INDIAGLYCO:India
Address Plot No. 2B, Sector - 126, District Gautam Budh Nagar, Noida, UP, IND, 201304
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
66GF Score

Get the complete analysis for BOM:500201

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,143.10
Price
₹757.98
GF Value